Three Reasons to Own Vertex Pharmaceuticals

It looks like Vertex Pharmaceuticals (VRTX) is showing early success in its drive to develop a three-drugs-in-one-pill combination for cystic fibrosis patents. The drug maker released promising, al be it pre-clinical, data at the North American Cystic Fibrosis Conference for a pair of triple-drug cocktails. Both therapies are now in early-stage human trials. At a […]